ctrl K

Watchlist Price Alert

Acurx Pharmaceuticals Inc... (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

0.35

0.00 (0.73%)

At close: Jun 06, 2025, 3:59 PM

0.34

-3.38%

After-hours: Jun 06, 2025, 05:57 PM EDT

Acurx Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-14.1M	-14.58M	-12.09M	-12.88M	-4.6M	-5.93M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-14.1B	-14.58M	-12.09M	-12.75M	-4.6M	-5.93M
Net Income	-14.1B	-14.58M	-12.09M	-12.75M	-4.6M	-5.93M
Selling & General & Admin	8.7M	8.53M	7.34M	10.78M	2.4M	2.42M
Research & Development	5.4M	6.04M	4.75M	2.03M	2.2M	3.51M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	14.1M	14.58M	12.09M	12.81M	4.6M	5.93M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-8.69B	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	14.58M	12.09M	12.81M	4.6M	5.93M
Income Tax Expense	n/a	n/a	-1.22K	-66.5K	n/a	n/a
Shares Outstanding (Basic)	16.16M	12.67M	10.82M	10.22M	9.92M	7.5M
Shares Outstanding (Diluted)	16.16M	12.67M	10.82M	10.22M	9.92M	4.75M
EPS (Basic)	-872.54	-1.15	-1.12	-1.24	-0.46	-0.6
EPS (Diluted)	-872.54	-1.15	-1.12	-1.24	-0.46	-0.6
EBITDA	-14.1M	-14.58M	-12.09M	n/a	-4.6M	-5.93M
EBIT	-14.1M	-14.58M	-12.09M	-12.75M	-4.6M	-5.93M
Depreciation & Amortization	n/a	14.58M	12.09M	12.81M	n/a	n/a